Terms: = Kidney tumors AND TFE3, RCCP2, 7030, ENSG00000068323, TFEA AND Clinical Outcome
6 results:
1. Histological and molecular characterization of TFEB-rearranged renal cell carcinomas.
Wyvekens N; Rechsteiner M; Fritz C; Wagner U; Tchinda J; Wenzel C; Kuithan F; Horn LC; Moch H
Virchows Arch; 2019 May; 474(5):625-631. PubMed ID: 30706129
[TBL] [Abstract] [Full Text] [Related]
2. Preoperative neutrophil-to-lymphocyte ratio predicts the surgical outcome of Xp11.2 translocation/tfe3 renal cell carcinoma patients.
Agizamhan S; Qu F; Liu N; Sun J; Xu W; Zhang L; Guo H; Gan W
BMC Urol; 2018 Jun; 18(1):60. PubMed ID: 29890986
[TBL] [Abstract] [Full Text] [Related]
3. XP11.2 translocation renal cell carcinoma: clinical experience of Taipei Veterans General Hospital.
Hung CC; Pan CC; Lin CC; Lin AT; Chen KK; Chang YH
J Chin Med Assoc; 2011 Nov; 74(11):500-4. PubMed ID: 22100019
[TBL] [Abstract] [Full Text] [Related]
4. A novel case of t(X;1)(p11.2;p34) in a renal cell carcinoma with tfe3 rearrangement and favorable outcome in a 57-year-old patient.
Haudebourg J; Hoch B; Fabas T; Burel-Vandenbos F; Carpentier X; Amiel J; Cardot-Leccia N; Michiels JF; Pedeutour F
Cancer Genet Cytogenet; 2010 Jul; 200(2):75-8. PubMed ID: 20620589
[TBL] [Abstract] [Full Text] [Related]
5. Xp11 translocation renal cell carcinoma.
Ross H; Argani P
Pathology; 2010 Jun; 42(4):369-73. PubMed ID: 20438411
[TBL] [Abstract] [Full Text] [Related]
6. Renal cell carcinoma with an Xp11.2 translocation in a 16-year-old girl: a case report with cytological features.
Mansouri D; Dimet S; Couanet D; Terrier-Lacombe MJ; Vasiliu V; Khalifa C; Suciu V; Vielh P
Diagn Cytopathol; 2006 Nov; 34(11):757-60. PubMed ID: 17121199
[TBL] [Abstract] [Full Text] [Related]
